Glucocorticoid Use Linked to Sarcopenia Development in Rheumatoid Arthritis
Researchers investigated the risk factors for developing sarcopenia in patients with rheumatoid arthritis, using the CHIKARA database.
Glucocorticoid
Anti-fracture Therapy Prevents Bone Loss in Women After Critical Illness
Prospective observational cohort study examines association between post-ICU administration of anti-fracture therapy or glucocorticoids and longitudinal changes in bone mineral density.
The Handoff: Your Week in Rheumatology News – 3/24/17
New guidelines for rheumatoid arthritis treatment with DMARDs and money being steered into lupus research highlight this week’s The Handoff.
Glucocorticoids for Early Rheumatoid Arthritis Demonstrate Good Long-term Safety
Researchers examined the long-term safety of glucocorticoid use in patients with early rheumatoid arthritis, defined as disease duration <6 months, from the multicenter observational Etude et Suivi des POlyarthrites Indifférenciées Récentes (ESPOIR) cohort.
Dose-Response Relationship Between Glucocorticoids and S. aureus Bacteremia Risk
Data from a population-based case control study found that systemic glucocorticoid use was associated with increased risk of S. aureus bacteremia (CA-SAB), with a clear dose-response relationship.
Quantification of Incident Diabetes Risk With Glucocorticoid Tx in RA
Recent glucocorticoid use contributed most to the current risk of diabetes, while doses taken more than 6 months previously did not.
EULAR Consensus on Long-Term Use of Glucocorticoids
A multidisciplinary EULAR task force reviewed the literature on dose-dependent risks related to glucocorticoid therapy in the management of chronic inflammatory rheumatic disease.
- Loading...
Loading...
Next post in Rheumatoid Arthritis
Loading... 
Loading...